J Gastroenterology:与SLCO2A1基因相关的慢性肠病不是克罗恩病

2018-10-13 MedSci MedSci原创

与SLCO2A1基因相关的慢性肠病(CEAS)是由SLCO2A1基因突变引起的遗传性疾病,其特征在于多种非特异性组织学的小肠溃疡。SLCO2A1也是原发性肥大性骨关节病(PHO)的致病基因。然而,目前我们对CEAS或PHO的临床特征知之甚少。

背景
与SLCO2A1基因相关的慢性肠病(CEAS)是由SLCO2A1基因突变引起的遗传性疾病,其特征在于多种非特异性组织学的小肠溃疡。SLCO2A1也是原发性肥大性骨关节病(PHO)的致病基因。然而,目前我们对CEAS或PHO的临床特征知之甚少。

方法
研究人员招募了2012年至2016年期间通过全国范围的CEAS调查的65名日本患者参加了本研究。并回顾了遗传检测证实的CEAS患者的临床信息。

结果
研究人员在46名患者的11个位点发现了隐性SLCO2A1突变。在46例基因证实为CEAS的患者中,13例为男性,33例为女性。疾病发作的中位年龄为16.5岁。45名患者(98%)出现贫血,而一名患者出现严重的血尿。所有患者在血液测试中显示相对低的炎症标记物(中位CRP 0.20mg / dl)。最常见的肠道部位是回肠(98%),尽管没有患者在回肠末端有粘膜损伤。13名患者(28%)发现了轻度杵状指或骨膜增生症,其中5名男性患者符合PHO的主要诊断标准。

结论
CEAS的临床特征与克罗恩病的临床特征不同。因此,对于临床怀疑患有CEAS的患者,推荐对SLCO2A1基因进行遗传分析。


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1711690, encodeId=bb3a1e116908d, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Wed May 08 01:23:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2072336, encodeId=346220e233644, content=<a href='/topic/show?id=9d4ee84647' target=_blank style='color:#2F92EE;'>#GAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7846, encryptionId=9d4ee84647, topicName=GAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2dd327, createdName=许安, createdTime=Wed Nov 28 00:23:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2064522, encodeId=584420645221d, content=<a href='/topic/show?id=94ffe853a7' target=_blank style='color:#2F92EE;'>#Gastroenterol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7853, encryptionId=94ffe853a7, topicName=Gastroenterol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bed488, createdName=jktdtl, createdTime=Fri May 10 10:23:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1504505, encodeId=dcb11504505a2, content=<a href='/topic/show?id=7730e85412' target=_blank style='color:#2F92EE;'>#Gastroenterology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7854, encryptionId=7730e85412, topicName=Gastroenterology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fc29706655, createdName=chaojitidian, createdTime=Mon Oct 15 05:23:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1711690, encodeId=bb3a1e116908d, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Wed May 08 01:23:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2072336, encodeId=346220e233644, content=<a href='/topic/show?id=9d4ee84647' target=_blank style='color:#2F92EE;'>#GAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7846, encryptionId=9d4ee84647, topicName=GAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2dd327, createdName=许安, createdTime=Wed Nov 28 00:23:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2064522, encodeId=584420645221d, content=<a href='/topic/show?id=94ffe853a7' target=_blank style='color:#2F92EE;'>#Gastroenterol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7853, encryptionId=94ffe853a7, topicName=Gastroenterol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bed488, createdName=jktdtl, createdTime=Fri May 10 10:23:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1504505, encodeId=dcb11504505a2, content=<a href='/topic/show?id=7730e85412' target=_blank style='color:#2F92EE;'>#Gastroenterology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7854, encryptionId=7730e85412, topicName=Gastroenterology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fc29706655, createdName=chaojitidian, createdTime=Mon Oct 15 05:23:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]
    2018-11-28 许安
  3. [GetPortalCommentsPageByObjectIdResponse(id=1711690, encodeId=bb3a1e116908d, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Wed May 08 01:23:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2072336, encodeId=346220e233644, content=<a href='/topic/show?id=9d4ee84647' target=_blank style='color:#2F92EE;'>#GAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7846, encryptionId=9d4ee84647, topicName=GAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2dd327, createdName=许安, createdTime=Wed Nov 28 00:23:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2064522, encodeId=584420645221d, content=<a href='/topic/show?id=94ffe853a7' target=_blank style='color:#2F92EE;'>#Gastroenterol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7853, encryptionId=94ffe853a7, topicName=Gastroenterol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bed488, createdName=jktdtl, createdTime=Fri May 10 10:23:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1504505, encodeId=dcb11504505a2, content=<a href='/topic/show?id=7730e85412' target=_blank style='color:#2F92EE;'>#Gastroenterology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7854, encryptionId=7730e85412, topicName=Gastroenterology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fc29706655, createdName=chaojitidian, createdTime=Mon Oct 15 05:23:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1711690, encodeId=bb3a1e116908d, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Wed May 08 01:23:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2072336, encodeId=346220e233644, content=<a href='/topic/show?id=9d4ee84647' target=_blank style='color:#2F92EE;'>#GAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7846, encryptionId=9d4ee84647, topicName=GAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2dd327, createdName=许安, createdTime=Wed Nov 28 00:23:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2064522, encodeId=584420645221d, content=<a href='/topic/show?id=94ffe853a7' target=_blank style='color:#2F92EE;'>#Gastroenterol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7853, encryptionId=94ffe853a7, topicName=Gastroenterol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bed488, createdName=jktdtl, createdTime=Fri May 10 10:23:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1504505, encodeId=dcb11504505a2, content=<a href='/topic/show?id=7730e85412' target=_blank style='color:#2F92EE;'>#Gastroenterology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7854, encryptionId=7730e85412, topicName=Gastroenterology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fc29706655, createdName=chaojitidian, createdTime=Mon Oct 15 05:23:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]

相关资讯

J Gastroenterology:抗肿瘤坏死因子治疗可降低炎症型克罗恩病初次腹部手术的风险

抗肿瘤坏死因子(TNF)疗法可以诱导并维持克罗恩病(CD)患者的临床缓解。然而,抗TNF治疗对CD自然病程的影响仍存在争议。因此,本项研究的目的是探究抗TNF治疗对CD初次肠道手术风险的影响。

JCC: CT评估皮下或内脏肥胖可预测克罗恩病患者的不良后果

本项研究的目的是评估需要腹部计算机断层扫描的克罗恩病患者,经过计算机断层扫描后,根据计算机断层扫描时的各种身体成分参数研究其与克罗恩病预后之间的关系。

IBD:治疗期间英夫利西单抗浓度与IBD患者的疾病缓解存在相关关系

克罗恩病的治疗结果的评价越来越讲究量化与客观性。研究人员就维持血清英夫利昔单抗波谷浓度与CD中生化,内镜或组织学缓解之间的关系进行了相关的探索。

J Gastroenterology: 克罗恩病患者中肠源干细胞的修饰与疾病活动存在相互影响

肠干细胞(ISCs)在维持体内平衡以及受损肠上皮的再生中发挥着不可或缺的作用。然而,克罗恩病(CD)的炎症环境是否会影响常驻小肠干细胞的特性仍然不明确,本项研究通过体外实验阐明了他们之间的关系。

BMC Gastroenterology:维多珠单抗可用于治疗抗TNF-α治疗失败的炎症性肠病患者

维多珠单抗(Vedolizumab)在治疗患有克罗恩病(CD)和溃疡性结肠炎(UC)的成年患者中是很有成效的;然而,其在治疗儿童炎症性肠病(IBD)患者中的数据很少。因此,研究人员评估了维多珠单抗(vedolizumab)在奥地利IBD患儿中的疗效情况。

Digestive Surgery:术前营养优化可以改善克罗恩病患者的手术结果

克罗恩病患者的术前准备因为疾病的复杂性而十分具有挑战性,并且目前学界没有关于营养支持的具体指导方案。本研究的目的是评估术前营养支持是否影响克罗恩病患者的术后结果。